Total Funding
35
6
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1272383
Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.
Timothy Macdonald: Founding Scientist
Paul H. Sartori: Vice President of Operations and Strategy
About the Company
Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville,
Virginia.
